Key facts
- It has raised $120.0M across 2 recorded rounds; the latest was Early Stage VC ($42.6M) in Aug 2023.
- Ikena Oncology has filed 2 Form Ds with the SEC since 2023, most recently Jul 2025 ( sold).
Free account
See the evidence behind this price
- ·Post-money valuations for all 2 rounds
- ·Watchlist + deal alerts for Ikena Oncology
Create free account
No card required
Funding rounds
2 roundsJan 2021Later Stage VC (Series B)$120.0M▮
About Ikena Oncology
- Industry
- Drug Discovery
PA Mark — not yet priced
Ikena Oncology doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Pro members can request priority coverage with a 48-hour turnaround.
Recorded secondary trades
No prints on record
No secondary trades in Ikena Oncology shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Pro members can request priority coverage with a 48-hour turnaround.
Institutional fund marks
No fund marks yet
No SEC-registered fund has reported a fair-value mark on Ikena Oncology in its N-PORT filings yet. We sweep new filings monthly.
Pro members can request priority coverage with a 48-hour turnaround.